Clinical Program Lead (CPL) - RLT Focus
Novartis
Summary
Location: Cambridge, MA. Hybrid. May consider DWA, but candidates local to onsite preferred. Experience will determine which level 6 (Senior CPL or CPL) is appropriate after interview process based on skills and experience.
Job description
Job Description Summary
Location: Cambridge, MA. Hybrid. May consider DWA, but candidates local to onsite preferred. Experience will determine which level 6 (Senior CPL or CPL) is appropriate after interview process based on skills and experience.
CPL: Provides strategic medical guidance and leads the development of experimental oncology agents in the TCO portfolio, beginning with PE / DC (Portfolio Entry / Drug Candidate) of preclinical development and continuing through TDP (Transition Decision Point).
Major Accountabilities
- Provides strategic medical and scientific leadership and expertise to all line functions on the project team for the development of new oncology agents (e.g., small molecules, biologics, radioligand therapies) that are in preclinical development, typically beginning at the PE / DC
- Creates clinical development strategies for new oncology agents within the PE/ DC to TDP timeframe, combining medical knowledge with expertise of colleagues in Clinical Pharmacology, Biostatistics and other disciplines
- Delivers solutions within functions, across functions, and on global projects, developing independent approach to TCO strategy
- Provides an early clinical development strategy that foresees and supports subsequent registration trials
- Develops the Integrated Development Plan Approval (IDPA) in alignment with CPL Disease Area Leads (DALs), Development (DEV), Strategy & Growth (S&G), and Commercial teams
- Leads Biomedical Research Early Program Teams (BPTs) to enable the start of clinical development and continuing through clinical trials needed to support TDP; may lead multiple global project teams
- Integrates preclinical information (pharmacology, toxicology, and pharmacokinetics) and interprets implications for clinical development, as articulated in the Investigator’s Brochure and First-in-Human protocol
- Collaborates with clinical scientists to develop clinical protocols for TCO compounds and develop the instruments needed to implement, interpret and report them (e.g., case report forms, report and analysis plans, clinical study reports)
- Applies own medical knowledge to guide the safe, ethical and efficient conduct of the trials under own responsibility; knowledgeable in Good Clinical Practice guidelines and Novartis Standard Operating Procedures
- Liaises with outside experts, investigators, and regulatory authorities in oncology, and represents own projects to those groups and authorities
- Writes and reviews abstracts/manuscripts for presentation/publications at internal/external meetings
- Participates in task forces to support continuous improvement and other management objectives; operational responsibility for quality and compliance
- May provide informal mentorship to less experienced CPLs
Qualifications
Education: MD or DO degree. Board-certification in an oncology specialty and PhD-level science are preferred.
Languages: Fluent English – Oral and written.
Experience/Professional requirement
- At least 2 years of pharmaceutical/biotech industry experience in oncology clinical trials plus the equivalent duration experience from an academic medical center
- If limited or no Pharmaceutical industry experience, then comparable senior academic experience in translational oncology and clinical research
- Experience within RLT preferred
- Recognized as an expert in your field by external medical experts; external candidates have a substantial record of publication and international recognition
- Excellent interpretation of oncology preclinical data (molecular biology, pharmacology, pharmacokinetics, and toxicology)
- Strong knowledge of the application of PK/PD and biostatistics to clinical development and clinical trials
- Proven ability to analyze and interpret efficacy and safety data relating to oncology
- Knowledge of GCP and world-wide regulatory requirements for clinical trials and oncology
- Excellent medical/scientific writing skills
- Successful track record of strategic thinking
- Proven ability to develop and inspire project/line/matrix multidisciplinary teams in a global environment
- Excellent personal ethical integrity and a commitment to improving the outcomes for patients with malignancies
- Excellent written and oral English communication/presentation skills
- Strong office IT skills
Requirements
- MD or DO degree
- At least 2 years of pharmaceutical/biotech industry experience in oncology clinical trials plus equivalent duration experience from an academic medical center
- If limited or no pharmaceutical industry experience, comparable senior academic experience in translational oncology and clinical research
- Fluent English – oral and written
- Excellent interpretation of oncology preclinical data (molecular biology, pharmacology, pharmacokinetics, and toxicology)
- Strong knowledge of the application of PK/PD and biostatistics to clinical development and clinical trials
- Proven ability to analyze and interpret efficacy and safety data relating to oncology
- Knowledge of GCP and world-wide regulatory requirements for clinical trials and oncology
- Excellent medical/scientific writing skills
- Successful track record of strategic thinking
- Proven ability to develop and inspire project/line/matrix multidisciplinary teams in a global environment
- Excellent personal ethical integrity and commitment to improving outcomes for patients with malignancies
- Excellent written and oral English communication/presentation skills
- Strong office IT skills
Benefits
- Health Benefits
- Life Insurance
- Disability Benefits
- 401(k) Matching
- Performance-Based Cash Incentive
- Annual Equity Awards
- Paid Vacation
- Personal Days
- Paid Holidays
- Other Leaves
Company overview
Novartis is a global pharmaceutical company headquartered in Basel, Switzerland, dedicated to reimagining medicine to improve and extend people's lives. As an innovative medicines company, Novartis focuses on developing high-value treatments that address society's greatest disease burdens through technology leadership in research and development. The company operates across five core therapeutic areas: cardiovascular, renal and metabolic diseases; immunology; neuroscience; oncology; and hematology. With a workforce of approximately 75,883 employees worldwide, Novartis reaches nearly 300 million patients across 118 countries. The company leverages advanced technology platforms including targeted protein degradation, cell therapy, gene therapy, radioligand therapy, and xRNA to develop breakthrough treatments. Novartis maintains a strong portfolio of oncology drugs and generics while continuously expanding its pipeline through strategic acquisitions and internal research. The company's commitment extends beyond drug development to ensuring global access to medical innovations through novel access approaches and patient assistance programs.